High-sensitive cardiac troponin for the diagnosis of acute myocardial infarction in different chronic kidney disease stages
- PMID: 33596833
- PMCID: PMC7888109
- DOI: 10.1186/s12872-020-01746-0
High-sensitive cardiac troponin for the diagnosis of acute myocardial infarction in different chronic kidney disease stages
Abstract
Background: Chronic kidney disease (CKD) are associated with acute myocardial infarction (AMI). High-sensitive cardiac troponin (hs-cTn) has been evidenced to enhance the early diagnostic accuracy of AMI, but hs-cTn levels are often chronically elevated in CKD patients, which reduces their diagnostic utility. The aim of this study was to derive optimal cutoff-values of hs-cTn levels in patients with CKD and suspected AMI.
Methods: In this retrospective paper, a total of 3295 patients with chest pain (2758 in AMI group and 537 in Non-AMI group) were recruited, of whom 23.1% were had an estimated glomerular filtration rate (eGFR) of < 60 mL min-1 (1.73 m2)-1. Hs-cTnI values were measured at presentation.
Results: AMI was diagnosed in 83.7% of all patients. The optimal value of hs-TnI in diagnosing AMI was 1.15 ng mL-1, which were higher in males than females comparing different cutoff-values of subgroups divided by age, gender and renal function, and which increased monotonically with decreasing of eGFR because in patients with CKD without AMI, the correlation between hs-cTnI and renal function is low but significant (r2 = 0.067, P < 0.001).
Conclusions: Different optimal cutoff-values of hs-cTnI in the diagnosis of AMI in patients with CKD were helpful to the clinical diagnosis of AMI in various populations and were higher in males than females, but which was needed to be validated by multicenter randomized controlled clinical studies in the future.
Keywords: Acute myocardial infarction; Chronic kidney disease; Estimated glomerular filtration rate; High-sensitivity cardiac troponin.
Conflict of interest statement
Authors stated no conflict of interest
Figures
References
-
- Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2015;108:2154–2169. doi: 10.1161/01.CIR.0000095676.90936.80. - DOI - PubMed
-
- Fox CS, Muntner P, Chen AY, et al. Acute Coronary Treatment and Intervention Outcomes Network Registry. Use of evidence-based therapies in shortterm outcomes of ST-segment elevation myocardial infarction and non–STsegment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010;121:357–365. doi: 10.1161/CIRCULATIONAHA.109.865352. - DOI - PMC - PubMed
-
- Wybraniec MT, Bożentowicz-Wikarek M, Chudek J, et al. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography. Int J Cardiovasc Imaging. 2017;33(5):595–604. doi: 10.1007/s10554-016-1039-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
